• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Baxter?s Vaccine Research Sent Bird Flu Across European Labs

Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

This Canadian piece revives a discrepancy I thought had been resolved. Namely where the contamination occurred.

When I phoned Baxter I was told it had occurred in Austria. Post #17 on the 18th
H3N2 seasonal flu vaccine was contaminated with HPAI H5N1 at an Austrian Baxter plant in a procedure which they are unable to go into but has been discontinued.
Bloomberg has it coming from the US. Post #34 on the 24th
The material came from Deerfield, Illinois-based Baxter, which reported the incident to the Austrian Ministry of Health, Sigrid Rosenberger, a ministry spokeswoman, said over the telephone today.
and the Canadian press moves it back to Austria. #39 on the 26th
Baxter International, which is based in Deerfield, Ill., said the contamination was the result of an error in its research facility in Orth-Donau, Austria.
The 'where' is a small point compared to the 'how' but it would be nice to get those facts they are willing to discuss clarified.
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

I guess, the Bloomberg reporter had read:

> Baxter International, which is based in Deerfield, Ill., ...

and then concluded the contamination had happened there
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

JJackson - I think your information is correct. Thanks again for contacting Baxter in such a timely manner.
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

A report dated 11.02.2009 , could be related? Baxter is in Vienna, these could be employees of Baxter involved in the contamination of the vaccine?


No bird flu case in Vienna =

Vienna (OTS) - On Monday last, (feb 9, ed) in Vienna
Otto-Wagner-Spital 18 female employees of an outside company
were treated as out-patients, as initially could not be ruled out,
that they in their work had come in contact with an avian influenza virus


In none of the tests, an infection was confirmed .****

In addition, the patients immediately were treated with a
Influenza preparedness treated. "Neither of the patients
nor for persons who are in contact with them were, there was a
Hazard. Obviously we informed all relevant
Authorities, "said Susanne Dr.in Drapalik by the
Directorate-General of the Hospitals of the City of Vienna.

http://www.ots.at/presseaussendung.php?schluessel=OTS_20090211_OTS0073

credits FMA, via Effect Measure
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

Laboratory incident through contaminated with H5N1 flu vaccine

13 employees of a Czech laboratory for a week unnoticed H5N1 viruses suspended -

Puzzling connection to a similar case in Austria.




(PR-inside.com 22.02.2009 15:57:23) - A supply of highly pathogenic H5N1 influenza virus vaccine kontamierten of Austria to the Czech Republic provides for risks of 13 laboratory staff. At the same time, 18 employees of an Austrian pharmaceutical laboratories in Vienna Otto Wagner Spital treated against "bird flu".

Czech media reports that it came in a laboratory of the 70 km east of Prague situated Biotest Ltd. Konarovice in a serious incident by highly pathogenic H5N1 virus contaminated vaccine.

According to the Scientific Forum Avian Influenza (WAI) the information the incident took place already on 06 February this year. The experimental vaccine was on 30.01.2009 by Avir Green Hills Biotechnology GmbH
Behalf of the pharmaceutical company Baxter Vienna to the laboratory of Biotest Ltd. has been delivered in the Czech Republic, where in this animal to be tested ferrets.

As part of the animal in the ferrets began to show symptoms and some of the animals died, was from Austria delivered vaccine investigated and any contamination with hazardous for human-pathogen avian flu H5N1 found. 13 laboratories of Biotest Ltd employees. Which over a period of approximately one week as part of their work contact with the highly pathogenic agents were preventive antiviral drugs. For an infection of the laboratory staff did not seem fortunately.

So far unexplained is the relationship of the laboratory incident in the Czech Republic to a report of the Press and Information Service of the City of Vienna 11.02. in which it is stated that the Vienna Otto Wagner Hospital, Citation: 18 employees of an outside company out-patients [were], because the moment could not be excluded that in the context of their work with a bird flu pathogen had been in contact '

According to the WAI arises, however, may be a causal link with a simultaneously taking place in Vienna Phase I study of an H5N1 vaccine live in the Austrian pharmaceutical company Baxter, under which a designed as a nasal spray bird flu vaccine tested on humans.

Whether the contamination of the vaccines actually in human phase I study in Vienna effect is unclear, but it would plausible to explain why at 11.02. - Five days after a laboratory accident by contaminated vaccine in the Czech Republic - Austria Vienna in 18 people in the Otto-Wagner-Spital preventively against H5N1 should be treated.


Although the laboratory incident is now the Biological Hazard from EDIS 'Emergency and Disaster Services), under the name BH-20090217-20552-CZE is listed, Baxter had been no public opinion forced.

The Science Forum avian influenza, therefore, strongly urges a full and detailed disclosure of the circumstances for which a vaccine contamination with highly pathogenic agents have led.

Already in 2004 there was a contamination of vaccines. The pharmaceutical manufacturer Chiron (now part of Switzerland's Novartis AG) had 46 million doses of Fluvirin flu vaccine due to bacterial contamination must be destroyed.

http://www.pr-inside.com/de/mitarbeiter-eines-tschechisch-r1073187.htm
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

(excerpts)
(...)

[2]
Date: Thu 26 Feb 2009
From: Christopher Bona <christopher_bona@baxter.com>


A statement on behalf of Baxter
-------------------------------
I would like to provide the following update to a posting on ProMED
dated 25 Feb 2009 (Avian influenza, accidental distribution - Czech
Rep. ex Austria: RFI).

The H5N1 strain was the A/Vietnam/1203/2004 strain, received from a
WHO reference centre. All information concerning this incident has
been provided to the involved national authorities and appropriate
international bodies such as ECDC and WHO.

Thank you and please contact me with questions.

--
Christopher Bona
Director, Global BioScience Communications
Corporate Communications
Baxter International Inc.
One Baxter Parkway
Deerfield, IL 60015
<christopher_bona@baxter.com>

[ProMED-mail thanks Christopher Bona for providing this precise
description of the strain of avian A/H5N1 influenza virus involved in
the incident. - Mod.CP]
</pre>-
http://apex.oracle.com/pls/otn/f?p=..._BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1000,76322
-----
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

May not be relevant but I remembered reading this
Baxter is currently the only vaccine manufacturer worldwide that has a commercial scale, cell culture-based manufacturing facility for future influenza vaccine production. The facility, located in Bohumil, Czech Republic, is engineered for BioSafety Level 3 production, and can produce up to 100 million doses of pandemic vaccine annually, depending on vaccine specification, dosage and yields of strains. Additionally, a Baxter pilot plant in Orth, Austria can produce smaller quantities of candidate vaccines for clinical trials using Vero cell technology.
from a Baxter document on their cell based flu vaccine technology. I was wondering if this may be where they were generating the test samples sent to Avir Green Hills and where the problem occured.
http://www.baxter.com/about_baxter/news_room/downloads/Vero_Cell_Backgrounder.pdf

Edit
I have just re-read Canadian press article which says it is which makes more sense than the Deerfield in Bloomberg.
 
Last edited:
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

> Bona said Baxter has identified how the contamination happened and has taken steps to
> ensure it doesn't happen again.

this is not just about Baxter, we want steps to be taken that it doesn't happen again elsewhere too.

> He said Austrian authorities audited Baxter's Orth-Donau
> research operations after the problem came to light and are satisfied with the steps taken.

so, did Baxter disclose to them how it happened ?

> "It was a combination of just the process itself, (and) technical and human error in this procedure,"
> Bona said. When asked to elaborate, he said to do so would give away proprietary information
> about Baxter's production process.

do we believe this ? And is it important enough to justify the secrecy ?
What sort of company proprietary information could be involved ?
We want to know how H5N1 contaminated the H3N2 samples. This can't be part
of the regular production process, they must have been handled separately,
so how can it be "proprietary information" ? And even if, in such a case, when people
are put at danger they can not hide behind it. There are bio-safety regulations,
which were accepted by Baxter and which must be surveilled.

It sounds more to me that Baxter's concern is public discussion about the issue
which they anticipate is bad for their image - rather than "proprietary information".

Can we expect this sort of secrecy when there are larger, real problems ?
Shouldn't we take steps now to avoid that in a possible pandemic ?
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

Obviously steps must be taken to not allow an pandemic starting because of machine or human errors.

This time seems that it was an error indeed.

And that all this cell based tecnology is choosed in good purpose (pandemic shielding).

But "the way to hell is full of good purposes" as written ...

So, Dutchy (thanks) wrote a post #47 with few sentences from an official Baxter web link about their cell tecnic.

Now, no matter the reason of this failure, independently, the biosecurity guideliness at everyone of the labs or productions sites must be upgraded, to shield the humanity from lab failures.

Even if we don't want to enter the production process details, an obviously good simple security solution, would be to make redundant all the production line checking points, and all the sensitive dangerous tecnical parts must have it's doubler which can start if happens an primary item failure.

The above is very well known, but (obviously) it is needed to being put more money for the process production expencies.

So, if the legislator wants to stop such potential doomsday events failures, the move is easy: no safety money for upgrading, no production ...

Here is an excerpt of the succus of the Baxter's public web pdf text release about the process (from the Dutchy post text with the quoted B. pdf text excerpt, #47 link):

http://www.baxter.com/about_baxter/news_room/downloads/Vero_Cell_Backgrounder.pdf

"VERO CELL BACKGROUNDER
Using Cell-Based Technology To Produce Vaccines
...

Cell-based manufacturing does not require weakened forms of the virus, resulting in vaccine availability after approximately 12 weeks.

This is significantly shorter than egg-based manufacturing, which may take up to 24 weeks.

Vero Cell Process
Baxter's Vero Cell technology uses a well-established cell line originaly derived from African green monkey kidney cells in 1962.
A continuous cell line has been derived from these cells so that an unlimited supply of cells is available without the requirement of generating additional cells from animals.

To produce a vaccine using Vero cell technology, a frozen vial of seed or starter virus is thawed and than injected into a large bioreactor, where it grows and reproduces.

The virus is than harvested from the bioreactor and inactivated.
It then undergoes purification and quality testing before it is formulated and filled into vials or syringes.

Baxter grows "wild-type", or natural, virus directly in its Vero cell culture, which reduces production time.

Wild-type virus is important because Baxter can work with the virus as it exists in nature, and create a vaccine with a better fit to the virus circulating in nature, as opposed to working with a geneticaly altered strain of the virus.

Also, Baxter's Vero cell system is capable of producing very high yields of influenza virus without the addition of any animal-derived serum.
The shorter production cycle and lack of raw material constraints allows for the implementation of rapid changes in strains that may be needed for new vaccine formulations.
..."


Above highlighted were some parts of the production process which can be subjected to more cross-over dual human checkings, and reinforced with dual-switching items in a case of machine failures.

P.S. Apart the preparation/production/check line, from other posts in this thread with news texts, it is not clear the link between this exp. vaccines production line, and the human birdflu vacc. trials in Austria.
In plain words, if we don't speak about events at the same site for both, what could be the link between an human vacc. by AH5N1 nasal live vacc., and the seasonal flu vacc. production process ...

Dutchy post #45 news text excerpt:
"Whether the contamination of the vaccines actually in human phase I study in Vienna effect is unclear, but it would plausible to explain why at 11.02. - Five days after a laboratory accident by contaminated vaccine in the Czech Republic - Austria Vienna in 18 people in the Otto-Wagner-Spital preventively against H5N1 should be treated. "
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

we'll have to know what was contaminated and how.

maybe the whole unit or large parts of it were contaminated,
who knows.
If it had been a small, avoidable error then why the secrecy ?
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

A/Vietnam/1203/2004 (see IOH's ProMED post #46) is being used by Baxter in Phase 3 clinical trials based in Austria.

The objectives of this study are to assess the immune response as well as the safety and tolerability of an H5N1 influenza vaccine in an adult and elderly population. Further, the study will assess the need for a booster vaccination and whether a 6-month booster or a 12-month booster is more appropriate. An independent data safety monitoring board will review and evaluate the safety data obtained in this study on an ongoing basis.


<table class="data_table" width="80%" border="1" cellpadding="5" cellspacing="0"><tbody><tr align="left"> <th class="header3 pale_banner_color"> Condition </th> <th class="header3 pale_banner_color"> Intervention </th> <th class="header3 pale_banner_color"> Phase </th> </tr> <tr valign="top" align="left"> <td class="body3" nowrap="nowrap"> Influenza
</td> <td class="body3" nowrap="nowrap"> Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen
</td> <td class="body3" nowrap="nowrap"> Phase III</td></tr></tbody></table>
<table style="margin-bottom: 3ex;" class="layout_table" border="0" cellpadding="0" cellspacing="0"><tbody><tr valign="top"><td nowrap="nowrap">Estimated Enrollment:</td> <td style="padding-left: 1em;">550</td> </tr> <tr valign="top"> <td nowrap="nowrap"> Study Start Date:</td> <td style="padding-left: 1em;">April 2007</td> </tr> <tr valign="top"> <td nowrap="nowrap"> Estimated Study Completion Date:</td> <td style="padding-left: 1em;">June 2009</td> </tr> <tr valign="top"> <td nowrap="nowrap"> Primary Completion Date:</td> <td style="padding-left: 1em;">June 2007 (Final data collection date for primary outcome measure)</td></tr></tbody></table>
<table class="layout_table" style="margin-bottom: 3ex;" border="0" cellpadding="0" cellspacing="0"><tbody><tr valign="top"><td nowrap="nowrap">
</td><td style="padding-left: 1em;">
</td></tr><tr valign="top"><td nowrap="nowrap">
</td><td style="padding-left: 1em;">
</td></tr><tr valign="top"><td nowrap="nowrap">
</td><td style="padding-left: 1em;">
</td></tr><tr valign="top"><td nowrap="nowrap">
</td><td style="padding-left: 1em;">
</td></tr></tbody></table>
Full details at link: http://clinicaltrials.gov/ct2/show/NCT00462215
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

CTV.ca | Baxter admits flu product contained live bird flu virus

Baxter admits flu product contained live bird flu virus

Updated Fri. Feb. 27 2009 2:56 PM ET
The Canadian Press
TORONTO --

The company that released contaminated flu virus material from a plant in Austria confirmed Friday that the experimental product contained live H5N1 avian flu viruses.


And an official of the World Health Organization's European operation said the body is closely monitoring the investigation into the events that took place at Baxter International's research facility in Orth-Donau, Austria.

"At this juncture we are confident in saying that public health and occupational risk is minimal at present," medical officer Roberta Andraghetti said from Copenhagen, Denmark.


"But what remains unanswered are the circumstances surrounding the incident in the Baxter facility in Orth-Donau."

The contaminated product, a mix of H3N2 seasonal flu viruses and unlabelled H5N1 viruses, was supplied to an Austrian research company. The Austrian firm, Avir Green Hills Biotechnology, then sent portions of it to sub-contractors in the Czech Republic, Slovenia and Germany.

The contamination incident, which is being investigated by the four European countries, came to light when the subcontractor in the Czech Republic inoculated ferrets with the product and they died. Ferrets shouldn't die from exposure to human H3N2 flu viruses.

Public health authorities concerned about what has been described as a "serious error" on Baxter's part have assumed the death of the ferrets meant the H5N1 virus in the product was live. But the company, Baxter International Inc., has been parsimonious about the amount of information it has released about the event.

On Friday, the company's director of global bioscience communications confirmed what scientists have suspected.

"It was live," Christopher Bona said in an email.

The contaminated product, which Baxter calls "experimental virus material," was made at the Orth-Donau research facility. Baxter makes its flu vaccine -- including a human H5N1 vaccine for which a licence is expected shortly -- at a facility in the Czech Republic.

People familiar with biosecurity rules are dismayed by evidence that human H3N2 and avian H5N1 viruses somehow co-mingled in the Orth-Donau facility. That is a dangerous practice that should not be allowed to happen, a number of experts insisted.

Accidental release of a mixture of live H5N1 and H3N2 viruses could have resulted in dire consequences.

While H5N1 doesn't easily infect people, H3N2 viruses do. If someone exposed to a mixture of the two had been simultaneously infected with both strains, he or she could have served as an incubator for a hybrid virus able to transmit easily to and among people.

That mixing process, called reassortment, is one of two ways pandemic viruses are created.

There is no suggestion that happened because of this accident, however.

"We have no evidence of any reassortment, that any reassortment may have occurred," said Andraghetti.

"And we have no evidence of any increased transmissibility of the viruses that were involved in the experiment with the ferrets in the Czech Republic."

Baxter hasn't shed much light -- at least not publicly -- on how the accident happened. Earlier this week Bona called the mistake the result of a combination of "just the process itself, (and) technical and human error in this procedure."

He said he couldn't reveal more information because it would give away proprietary information about Baxter's production process.

Andraghetti said Friday the four investigating governments are co-operating closely with the WHO and the European Centre for Disease Control in Stockholm, Sweden.

"We are in very close contact with Austrian authorities to understand what the circumstances of the incident in their laboratory were," she said.

"And the reason for us wishing to know what has happened is to prevent similar events in the future and to share lessons that can be learned from this event with others to prevent similar events. ... This is very important."
-
<cite cite="http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20090227/Bird_Flu_090227/20090227?hub=Health">CTV.ca | Baxter admits flu product contained live bird flu virus</cite>
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

it would be useful, if they could test for reassortments in ferrets...
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

it would be useful, if they could test for reassortments in ferrets...

Why?

We know reassortment happens.

We have a pretty solid idea of what the different gene combinations do and don't do.

I'm curious as to what you feel testing for reassortments in ferrets would produce that would be of benefit to our knowledge/understanding.
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

hat tip Revere -

Questions about bird flu contaminated vaccine -- or something

Category: Big PharmaBird fluVaccines
Posted on: February 26, 2009 6:42 AM, by revere

<!--proximic_content_on--> As I write this the story is still hazy [see Addendum] but it sounds like the kind of colossal screw-up we had four years ago when the American College of Pathology sent a pandemic flu strain (H2N2) to thousands of clinical and hospital laboratories as part of routine competency testing (see here, here, here). That was inattention by CDC, whose Director was mesmerized by the bioterrorism phantom and couldn't see beyond them. This time it's a vaccine maker and the cock-up sounds pretty horrendous, although it is hard to figure out exactly what has happened given the incomplete descriptions and lack of information from the parties involved:
Baxter International Inc. in Austria unintentionally contaminated samples with the bird flu virus that were used in laboratories in three neighboring countries, raising concern about the potential spread of the deadly disease. The contamination was discovered when ferrets at a laboratory in the Czech Republic died after being inoculated with vaccine made from the samples early this month. The material came from Deerfield, Illinois-based Baxter, which reported the incident to the Austrian Ministry of Health, Sigrid Rosenberger, a ministry spokeswoman, said today in a telephone interview.
"This was infected with a bird flu virus," Rosenberger said. "There were some people from the company who handled it."
The material was intended for use in laboratories, and none of the lab workers have fallen ill. The incident is drawing scrutiny over the safety of research using the H5N1 bird flu strain that's killed more than three-fifths of the people known to have caught the bug worldwide. Some scientists say the 1977 Russian flu, the most recent global outbreak, began when a virus escaped from a laboratory.
The virus material was supposed to contain a seasonal flu virus and was contaminated after "human error," said Christopher Bona, a spokesman for Baxter, in a telephone interview. (Michelle Fay Cortez and Jason Gale, Bloomberg)
On first reading this took my breath away because it sounded like a seasonal flu vaccine had become contaminated with H5N1. On second (and third) reading I am not sure what actually did happen and to whom. Here's what I am unsure about:

  • What was contaminated? The Bloomberg story refers to "samples," but samples of what?
  • Ferrets succumbed after failing ill after being "inoculated" with vaccine made from the samples. Does this mean it was a live virus vaccine? (inoculation usually means something living; if it were a vaccine without live materials you would ordinarily say "vaccinated" but people don't always use words precisely).
  • The contaminated material was "for use in laboratories." What does this mean? It was raw material in a lab that was then made into something else for use outside the lab (like a vaccine)?
  • The contaminated material was supposed to have seasonal flu virus in it, not bird flu virus. It sounds like it had both. ("The company was "supposed to get non-infected testing vaccine, which was by mistake of the supplier contaminated with the H5N1 virus"). That's a recipe for reassortment between a human and a bird virus. Not the dish I'd like to see served up.
  • Did this happen with a vaccine in clinical trials?
  • We are told that no lab worker has fallen ill. How were they exposed?
  • Labs have been "sanitized." What exactly does this mean? How was the lab contaminated?
Maybe this isn't the mess it sounds like. It would be nice to have more information from European health authorities. US CDC is apparently not playing any role, which suggests no US seasonal vaccines are involved. But the source of the contaminated sample was a US company, so inquiry from some US authorities seems appropriate.
That's not happening as far as we are told. Why not? Lots of questions. Few answers.


Addendum: After drafting this post which was based on published reports, I saw Helen Branswell's story (via crof's blog). It doesn't answer all the questions, but it is characteristically excellent reporting. Rather than summarize the wealth of additional details, go read Branswell's story. Still, many details are still unclear and Baxter is claiming confidential business information. This seems like something CDC might well want to investigate. Just my opinion.

<!--proximic_content_off--><!-- This is a linked template. Don't mess with it. --> <script type="text/javascript" src="http://w.sharethis.com/widget/?tabs=web%2Cemail&charset=utf-8&services=%2Cdigg%2Creddit%2Cstumbleupon%2Cdelicious%2Cfacebook%2Cmyspace%2Cnewsvine%2Cmagnolia%2Cgoogle_bmarks%2Ctechnorati%2Cblinklist%2Cpropeller%2Cmixx%2Cblogmarks%2Ctailrank%2Cfurl&style=rotate&publisher=f5d369e4-d10b-48d8-9015-ee0c80d2c43f&inactivebg=%23f2f2f2&inactivefg=%23333333&linkfg=%230054a6"></script>ShareThis Find more posts in: Medicine & Health
Comments

snip


The notion that Baxter is not reporting out all the details due to propietary production secrecy needs is beyond outrageous.
Sending H5N1 contaminated virus samples to three countries should qualify as a public health incident of global concern, and the International Health Regulations should kick in.
Delaying public reporting of this potential catastrophe for weeks is unforgiveable and reprehensible.
Baxter should be forced to publicly explain every step of its investigation and findings, so that other companies, universities, and government labs can check their security processes against what went wrong at Baxter.
Let me translate what Baxter said: "We care much more about profit than about global public health. We'd rather not reveal how we might have launched the next pandemic than tell you anything about how we (mis)handled H5N1."
Who provided the H5N1 sample to Baxter? Ultimately, probably a WHO collaborating lab. WHO should immediately ban Baxter from receiving any further samples of any sort from any WHO collaborating lab -- until Baxter offers a fully candid, transparent, honest report about what happened, and until WHO, the governments, and the publics of the effected countries have no further questions or concerns about Baxter's competence and candor.
Posted by: Jody Lanard M.D. | February 26, 2009 1:37 PM


snip


The research work being performed by Biotest was called to a halt on the 6th (Friday), after the ferrets started dying.
Posted by: JJackson | February 26, 2009 2:03 PM


What I should have made clear is that Biotest is the Czech lab that was contracted by to Avir Green Hills which in turn was contracted by Baxter (Austria). It is a little over 200 miles, as the crow flies, from Biotests labs in Konárovice to Vienna.
Posted by: JJackson | February 26, 2009 2:48 PM


Correct me if I am wrong, but it is my understanding that H5N1 can’t be grown in chicken embryos (the usual substrate for flu virus growth) because it kills them too quickly.
So how did they grow the virus they sent out for testing? Mammalian cell culture?
I agree with Revere, the danger is in the potential for recombination when H5N1 is co-grown with other flu virus, which they already seem to have done in this case.
The quote in the Bloomberg article was a little disingenuous, “even if it were let out of the lab, would be only lethal for birds in its present state,” um, then why did the ferrets die? Are ferrets a new kind of bird?
Or are they saying that H5N1 did recombine into something that was lethal for mammals and it is the recombined form that killed the ferrets?

Posted by: daedalus2u | February 26, 2009 3:35 PM


daedalus2u
If you want to grow HPAI H5N1 in eggs you do a bit of engineering first so the HA & NA sites still produce good antibodies but you lose the virulence.
As to the quote Baxter are in full spin mode and releasing no information about how the contamination occured. Keeping quiet has been effective form the 6th for a little over 2 weeks but the first stories appeared in the Czech press on the 17th (hat tip Dutchy @ Flutrackers) but was not picked up by MSM until the Bloomberg article.
I don't think Baxter's plan was going to work as the regulatory authorities in four european countries (and possibly the US if "The material came from Deerfield, Illinois" is correct and there is question mark about that). I hope Jody will come back after this is all over and give us a post game analysis on Baxter's communication stratagy.
Posted by: JJackson | February 26, 2009 3:57 PM


...is this another coincidence or is this a part of explanation?
http://www.european-hospital.com/topics/article/1182.html
Posted by: franc | February 26, 2009 5:48 PM


franc: I'm with you. I'll bet this is part of the explanation. Right now, though, Baxter is not being very forthcoming. European authorities should force their hand, assuming they want to. Maybe the don't.
Posted by: revere
mt_logo.png
| February 26, 2009 5:59 PM


daedalus2u: ordinarily, you're right (about growing h5n1 in eggs), which is why you need to use reverse genetics (as jjackson said, taking the internal genes from an h1n1 strain ("pr8") and mixing it with the h5 and n1). but, baxter uses mammalian tissue culture cells in their preparation, which allows them to grow fully virulent h5n1 without doing any modifications.
Posted by: Brendan | February 26, 2009 10:17 PM


jjackson: my understanding from the canadian article linked by revere is that avir green hills contracted the h3n2 from baxter, not the other way around. (from the article: "The facility had been contracted by Avir Green Hills to make what Baxter refers to as "experimental virus material" based on human H3N2 viruses.")
avir green hills is working on a seasonal and pandemic vaccine, and i believe both are live-attenuated. i find it really weird that baxter, which is a vaccine company, denies that what they shipped avir green hills, et al. was a vaccine. instead, they said it was a "liquid virus product." i have no idea what this could be.
Posted by: Brendan | February 26, 2009 10:26 PM


snip


Brendan
I do not think the contaminated sample came from the US (as in the Baxter article). I think it was made at "Baxter['s] pilot plant in Orth, Austria can produce smaller quantities of candidate vaccines for clinical trials using Vero cell technology" (the bit in quotes is from a Baxter doc on their Vero cell based vaccine technology. They have a production facility "The facility, located in Bohumil, Czech Republic, is engineered for BioSafety Level 3
production, and can produce up to 100 million doses of pandemic vaccine annually,depending on vaccine specification, dosage and yields of strains").
As explained by a Baxter spokesman the 'error' occurred in Baxter Austria and they had subcontracted some research to AGH (Austria). AGH subcontracted work on the 'experimental Vaccine' to Biotest, and others, and forwarded it on the 30th Jan. (Friday). Biotest began trials the following week by the end of which they had dead ferrets and an obvious problem. On the following Monday (11th) people were being given Tamiflu in Vienna so someone knew or suspected H5N1 exposure. First press involvement was local to Biotest in the Czech republic at the end of that week (dated 17th) and spread from their. That is the chronology as I understand it and all players thought they were dealing with H3N2 and used appropriate protocols.
None of which is very interesting, apart from a PR point of view. What we want to know is the nature of the H3N2 entity. Was it live or a vaccine, what is the nature of the H5N1 (dead ferrets and prophylactic Tamiflu so assumed live), how the two ever managed to be in the same place at the same time to allow contamination and having occurred how it then got out of the BSL3 facility and into civi street. None of which Baxter seem willing to discuss.
Posted by: JJackson | February 27, 2009 8:47 AM


P.S.
The H5N1 was A/Vietnam/1203/2004 which is being used by Baxter in phase 3 clinical trials in Austria (NCT00462215)
Posted by: JJackson | February 27, 2009 9:20 AM


Thank you, Revere! Curiouser and curiouser - so does anyone know if that "liquid virus product" went out to any other labs? (say in other countries)
Posted by: Steph | February 27, 2009 1:21 PM
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

hat tip Revere -

Baxter bird flu botch

Category: Big Pharma ? Bird flu ? Vaccines
Posted on: February 28, 2009 7:04 AM, by revere


<!--proximic_content_on--> In a post the other day on some kind of flu vaccine mishap in Austria we called it a colossal screw-up. It turns out we may have understated the case. Maybe. Because while more details are leaking out, the company responsible for it, Baxter International, isn't saying exactly what happened on the grounds that it is confidential business information. You almost have to admire that kind of arrogance. Almost. Meanwhile Helen Branswell brings us more details:
The company that released contaminated flu virus material from a plant in Austria confirmed Friday that the experimental product contained live H5N1 avian flu viruses. And an official of the World Health Organization?s European operation said the body is closely monitoring the investigation into the events that took place at Baxter International?s research facility in Orth-Donau, Austria.
[snip]
The contaminated product, a mix of H3N2 seasonal flu viruses and unlabelled H5N1 viruses, was supplied to an Austrian research company. The Austrian firm, Avir Green Hills Biotechnology, then sent portions of it to sub-contractors in the Czech Republic, Slovenia and Germany. (Helen Branswell, Canadian Press, via The Sun)
One of the big fears is that people or animals co-infected with a seasonal flu virus of humans and a virulent avian flu virus like H5N1 will act as a mixing vessel. Flu viruses each have eight genetic packages within them and when co-infecting a cell they can mix and match (reassortment), thus producing new hybrid bird-human viruses. Baxter put both viruses in the same vial, presumably for use as a vaccine. Baxter is calling the mixture an "experimental virus material," whatever that is. All we know is that a nasty live virus cocktail of human and bird influenza virus was made (Baxter says accidentally). Exactly to whom it was given, if anyone, is not being publicly divulged. We have a news report from an Austrian paper dated February 11, a Wednesday, that tells of 19 people being seen as outpatients at a Vienna hospital the previous Monday (February 9) because of exposure to "bird flu virus." The article said no one was sick, there was no evidence of infection, and the females were prophylaxed with antivirals (presumably Tamiflu).
WHO's European regional office in Copenhagen is saying they are confident there is no public or occupational health risk "at present," but they also acknowledge they don't know exactly what happened. They also say they do not any evidence that any reassortment occurred. I'm not sure exactly what evidence they looked at or have available, so I don't know how to interpret this absence of evidence. I'm certainly not reassured that unlabeled live H5N1 virus was released, even if just to another lab. There are people and animals in laboratories that were exposed and could have resulted in the virus getting into the general community in a major city with many international links.
Baxter's not saying much. Branswell quotes a company spokesperson as saying the incident happened through a combination of ?just the process itself, (and) technical and human error in this procedure.? This doesn't sound very reassuring, either, because it sounds like there is a process that is error prone ("technical" and human). If Baxter's name sounds familiar it may be because almost exactly a year ago they were in the news over a series of fatal allergic reactions among dialysis patients who used the blood thinner heparin they manufactured. It turned out their heparin came from China and contained an adulterant, oversulfated chondroitin sulfate. Patients in six countries and over a dozen states in the US had serious adverse reactions and more than 80 deaths. At the time, Baxter said on their website that they "will not sell another vial of heparin until the company has helped to create a system in which the quality and safety of heparin is secured." (Medpage Today)
They weren't saying anything about the safety of their bird flu products, then. And not much now, either.
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

Why?

We know reassortment happens.

We have a pretty solid idea of what the different gene combinations do and don't do.

I'm curious as to what you feel testing for reassortments in ferrets would produce that would be of benefit to our knowledge/understanding.


reassortments usually create new strains which spread better or even cause pandemics.
These are the big steps in flu eveolution which we are afraid of.
Concern was, that H5N1 might reassort with human H3N2 or H1N1,
and I think that most experts consider this as the more likely
way how a "H5N1" pandemic might emerge.

Some of these reassortments had been tested before (I remember one such study in 2006
and one in 2007 or 2008), it got quite some attention and we had discussed it.
But it was only tested for viability, not transmission.
And just for very few pairs of viruses, reassortment combinations, while flu evolves fast
and similar viruses may show quite different reassortment behaviour.

I think we need more reassortment tests, with more different viruses
in labs,cell cultures also naturally in ferrets(mice,guinea pigs) and
whether it spreads.

Such experiments were also useful to determine where seasonal flu might go.
The last semi-pandemic was caused in 2003 by such an reassortment in H3N2,
it might have been possible to test and predict it.

---edit--------
found the links:
http://www.plospathogens.org/articl...2;jsessionid=A99956E4E23CE55B553C6B4904C26D08
http://www.pnas.org/content/103/32/12121.full
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

Hummm... I certainly enthusiastically support scientific inquiries, and I believe even a small contribution to our pool of knowledge is worthwhile and valuable.

Do we not yet know with enough certainty that PB2 is where the transmission "key" resides? With today's technological abilities we do not have to infect 100's or 1,000's or even 10,000's [or more] of any mammal, for this discussion, ferrets, to wait and see if/when/how that rare reassortment happens... we can just build our own custom viruses.

So, on this envisioned experiment I would disagree with you. The number of ferrets might be staggering and the length of time might be great. The amount of lab manipulated H5N1, along with the [potential] time frame, argues against the "natural way" and introduces a greater degree of potential for "bad things" to happen because of the ongoing experiment... Baxter may be too fresh in my mind not to appreciate the simple fact in life that sometimes "crap happens".
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

but for testing transmissability you need animals

also reassortment happens in cells. In specific cells.
This depends on the whole organism, hard to predict in a lab.

So a "zoo" of double-infected animals (swine ?) would be useful
to study reassortments.
 
Re: Baxter?s Vaccine Research Sent Bird Flu Across European Labs

Absolutely, you do need animals to test for transmission traits/ability. However, you do not need animals to act as the "random mixing pots" of viral evolution. We can simply create the viruses we wish to test and then test them... far more efficient IMO.
 
Back
Top Bottom